Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:50 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Sleep Disturbance
Interventions: Sleep Supplement, Placebo; Dietary Supplement · Drug
Lead sponsor: Bonafide Health; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Harrison, New York

Conditions: Sleep Apnea, Obesity
Interventions: Not listed
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 182 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Insomnia, Suicidal Ideation
Interventions: Behavioral Insomnia Treatment; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Sleep Apnea, Obstructive, Sleep Apnea, Central
Interventions: Smart CO2; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 75 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Sleep Problems, Depressive Disorder and Anxiety Disorders
Interventions: Melatonin lotion, Placebo lotion; Other
Lead sponsor: University of Redlands; Other
Eligibility: 18 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Redlands, California

Conditions: Idiopathic Hypersomnia
Interventions: TAK-925, TAK-925 Placebo; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 20
States / cities: Alabaster, Alabama • Glendale, Arizona • Little Rock, Arkansas + 17 more

Conditions: Narcolepsy
Interventions: Samelisant, Placebo; Drug
Lead sponsor: Suven Life Sciences Limited; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Parkinson Disease, REM Sleep Behavior Disorder
Interventions: Speech assessment, Routine clinical assessment; Other
Lead sponsor: Czech Technical University in Prague; Other
Eligibility: 50 Years to 80 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sleep Apnea
Interventions: Inspired oxygen (40%), Sham; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 20 Years to 79 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Apnea
Interventions: Danavorexton, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 19
States / cities: Sheffield, Alabama • Phoenix, Arizona • La Jolla, California + 14 more

Conditions: Obstructive Sleep Apnea
Interventions: Low Calorie Diet, Very Low Calorie Diet, Standard Care; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 21 Years to 75 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Premature Birth, Asthma in Children, Sleep-Disordered Breathing, Neurodevelopmental Disorders
Interventions: Not listed
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 30 Weeks to 83 Months
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Insomnia
Interventions: Not listed
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sleep Apnea, Obstructive, Chronic Obstructive Pulmonary Disease
Interventions: Not listed
Lead sponsor: Incyphae, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 272 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Burlingame, California • New London, Connecticut • Lanham, Maryland

Conditions: PCOS, PCOS (Polycystic Ovary Syndrome), OSA, OSA - Obstructive Sleep Apnea
Interventions: Continuous Positive Airway Pressure (CPAP); Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obese, Pregnancy, Sleep Disordered Breathing
Interventions: CPAP, sham-CPAP, Sleep hygiene; Device · Other
Lead sponsor: Francesca Facco, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Sleep Apnea, Obstructive
Interventions: Under-mattress sleep monitor; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 22 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Dementia, Alzheimer Disease, Circadian Rhythm Disorders, Circadian Rhythm Sleep Disorder, Insomnia, Hypersomnia, Cognitive Impairment, Cognitive Decline, Mild Cognitive Impairment, Frontotemporal Dementia, Neurocognitive Disorders, Vascular Dementia, Sleep Disorder, Memory Impairment
Interventions: Attention-Control Condition, Timed Activity Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 110 Years
Enrollment: 421 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lewy Body Disease, Dementia, Parkinsonism, Mild Cognitive Impairment, REM Sleep Behavior Disorder
Interventions: meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy; Drug · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cognitive Impairment, Dementia
Interventions: Cognitive Behavioral Therapy for Insomnia (CBTi) via Videoconference; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Multiple Sclerosis, Fatigue, Insomnia
Interventions: Suvorexant, Placebo; Drug
Lead sponsor: Theodore R. Brown, MD MPH; Other
Eligibility: 18 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Kirkland, Washington

Conditions: Obstructive Sleep Apnea
Interventions: RXiBreeze PAP System, Model RXiBreeze 20A; Device
Lead sponsor: Resvent Holding USA LTD; Industry
Eligibility: 22 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 9
States / cities: Burlingame, California • Chula Vista, California • Mountain View, California + 6 more

Conditions: Major Depressive Disorder, Primary Hypersomnia, Bipolar Disorder, Narcolepsy, Primary Insomnia
Interventions: Acoustical slow wave induction; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 60 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Preeclampsia, Hypertension
Interventions: Positive Airway Pressure; Device
Lead sponsor: University of Michigan; Other
Eligibility: 14 Years and older · Female only
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

A Study of a Sleep Supplement to Improve Sleep in Women Going Through Menopause

Sleep Apnea in Pregnancy Screening Study

A Sleep-Oriented Intervention for Suicidal Behaviors

Variable Dead Space Rebreathing Device to Treat Sleep Apnea

The Impact of Melatonin Lotion on Sleep and Mental Health

A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia

A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)

Detecting Parkinson's Disease Through Speech Analysis

Estimating Apnea Phenotypes From Polysomnography: Oxygen

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults

Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age

Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

PMOS in OSA Pilot Study

Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)

Evaluating an Under-mattress Sleep Monitor Compared to a Peripheral Arterial Tonometry Device in the Diagnosis of Obstructive Sleep Apnea

The Healthy Patterns Sleep Study

MIBG in Aging and Neurologic Disorders

Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad

A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Neurophysiologic Correlates of Hypersomnia

Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure